Biomarker Testing Market Boosted by Growth in Precision Medicine and Companion Diagnostics | QIAGEN N.V., Bio-Rad Laboratories, Inc., Illumina, Inc., Labcorp Drug Development, IQVIA, Inc.

The global biomarker testing services market was valued at USD 651.28 million in 2024 and is expected to reach USD 1.12 billion by 2033, registering a CAGR of 8.9% between 2025 and 2033.

Biomarker Testing Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With the increasing focus on precision medicine, rapid advancements in molecular technologies, and expanding applications across oncology and neurology, the report delivers strategic insights to support stakeholders from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/biomarker-testing-market?ophp

Biomarker testing identifies biological molecules indicative of normal or diseased states, especially in cancer, cardiovascular, and neurological diseases. This market is expanding due to the growing emphasis on precision medicine, rising prevalence of chronic diseases, and technological advancements in genomics and proteomics.

Biomarker Testing Market Competitors Overview:

QIAGEN N.V., Bio-Rad Laboratories, Inc., Illumina, Inc., Labcorp Drug Development, IQVIA, Inc., Quanterix Corporation, Merck KGaA, Abbott Laboratories, Thermo Fisher Scientific Inc., and Q2 Solutions among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ On May 16, 2025 The FDA approved Fujirebio's Lumipulse G p‐tau217/β‐Amyloid 1‐42 plasma ratio test, the first blood-based biomarker assay for early Alzheimer's diagnosis in adults aged ≥55. This non-invasive test offers high sensitivity for detecting amyloid plaques without requiring a lumbar puncture or PET scan

✅ Foresight Diagnostics + QIAGEN (mid‐2025) - Formed an alliance to develop and commercialize a kit-based MRD (minimal residual disease) assay for lymphoma, pushing decentralized ctDNA testing into community settings

Methodology and Scope

The Biomarker Testing Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biomarker-testing-market?ophp

Biomarker Testing Market Segments Overview:

∎ By Test Type
Tumor Testing
Genomic Testing
Molecular Testing
Somatic Testing
Next Generation Sequencing

∎ By Biomarker Type
Diagnostic Biomarkers
Prognostic Biomarkers
Predictive Biomarkers

∎ By Application
Drug Discovery and Development
Disease Diagnostics
Disease Risk Assessment
Personalized Medicine
Others

∎ By End-User
Hospitals
Clinical Laboratoratories
Academic and Research Institutes
Others

The diagnostic biomarkers segment holds the largest share due to their essential role in disease detection and monitoring across a wide range of conditions, particularly in oncology.

Regional Overview for Biomarker Testing Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America holds the top share, with biomarker-driven clinical trials and precision diagnostics. Asia Pacific is growing fastest due to expanding biotech ecosystems.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=biomarker-testing-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Biomarker Testing market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Biomarker Testing market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.